Clinical Trials on Relapsed, Refractory Multiple Myeloma
Total 4794 results
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsWithdrawnRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | HLA-A*0201 Positive Cells Present | NY-ESO-1 Positive Tumor Cells PresentUnited States
-
Beijing 302 HospitalNot yet recruitingRefractory Acute Myeloid Leukemia | Minimal Residual Disease | Relapsed Acute Myeloid Leukemia
-
Massachusetts General HospitalPatient-Centered Outcomes Research InstituteRecruitingHigh Risk Acute Myeloid Leukemia | Relapsed Adult AML | Primary Refractory Acute Myeloid LeukemiaUnited States
-
University of PennsylvaniaRecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia, Adult | Acute Myeloid Leukemia, RefractoryUnited States
-
Ciusss de L'Est de l'Île de MontréalUnknownRelapsed Multiple Myeloma | Relapsed Non Hodgkin Lymphoma | Hematologic Cancer | Relapsed Adult AML | Relapse Leukemia | Relapsed Adult ALL | Relapsed CLL | Relapsed Hodgkin's Lymphoma | Relapsed Myelodysplastic SyndromesCanada
-
St. Jude Children's Research HospitalSyndax PharmaceuticalsRecruitingRefractory Acute Myeloid Leukemia | Acute Leukemia of Ambiguous Lineage | Relapsed Acute Myeloid LeukemiaUnited States
-
Catherine BollardJohns Hopkins University; Children's National Research InstituteRecruitingRelapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDSUnited States
-
EMN Research ItalyActive, not recruitingRelapsed Multiple MyelomaItaly
-
Istituto Scientifico Romagnolo per lo Studio e...Charite University, Berlin, Germany; University of Bologna; Hannover Medical... and other collaboratorsNot yet recruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryItaly
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada, United Kingdom, France, Belgium, Austria, Spain, Israel, Italy, Bulgaria, Czechia, Germany, Greece, Hungary, Netherlands, Poland, Romania, Russian Federation, Serbia, Sweden
-
Centre Hospitalier le MansCompleted
-
Herlev HospitalOdense University HospitalCompletedRelapsed Multiple MyelomaDenmark
-
University of IowaCompleted
-
Masonic Cancer Center, University of MinnesotaCompletedRelapsed Acute Myelogenous Leukemia | Refractory Acute Myelogenous LeukemiaUnited States
-
Arog Pharmaceuticals, Inc.CompletedAcute Myeloid Leukemia With FLT3 Activating Mutations That Has Relapsed or Been Refractory After One or More Prior TherapiesUnited States
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada
-
Mario BoccadoroActive, not recruiting
-
University of California, San FranciscoCompletedRefractory Plasma Cell Myeloma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Plasma Cell Myeloma | Recurrent Malignant Neoplasm | Refractory Malignant Neoplasm | Recurrent High Grade B-Cell Lymphoma | Refractory High Grade B-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
Hannover Medical SchoolUniversity Hospital, Ghent; Johann Wolfgang Goethe University Hospital; University... and other collaboratorsUnknownDe Novo Akute Myeloid Leukemia (AML) | Secondary Acute Myeloid Leukemia (AML) | Refractory Anemia With Excess of Blasts in TransformationGermany
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruitingRefractory Acute Myeloid Leukemia | Conditioning | Hematopoietic Stem Cell Transplantation | Relapse Leukemia
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Eli Lilly and Company; Kanisa PharmaceuticalsCompletedMyelodysplastic Syndromes | LeukemiaUnited States, Israel
-
Nanjing Chia-tai Tianqing PharmaceuticalRecruitingRelapsed/Refractory Acute Myeloid Leukemia (AML)China
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingRecurrent and Refractory Non-Hodgkin's Lymphoma and Multiple MyelomaChina
-
National Cancer Institute (NCI)TerminatedStage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
Shanxi Bethune HospitalRecruiting
-
University of ChicagoGlaxoSmithKline; AmgenRecruitingMultiple Myeloma | Relapse Multiple MyelomaUnited States
-
Sheba Medical CenterRecruitingMultiple Myeloma | Relapse Multiple MyelomaIsrael
-
University of Colorado, DenverNational Cancer Institute (NCI); Karyopharm Therapeutics IncRecruitingMultiple Myeloma in RelapseUnited States
-
Turkish Hematology AssociationRecruitingMultiple Myeloma | Relapse Multiple MyelomaTurkey
-
Travera IncMassachusetts General Hospital; Dana-Farber Cancer Institute; Weill Medical College... and other collaboratorsRecruitingMultiple Myeloma in RelapseUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.; Celgene CorporationActive, not recruitingMultiple Myeloma in RelapseUnited States
-
Raija SilvennoinenBristol-Myers Squibb; Amgen; Hospital District of Helsinki and UusimaaCompletedMultiple Myeloma in RelapseFinland, Sweden
-
iOMEDICO AGAmgenActive, not recruiting
-
Molecular Partners AGCompletedMultiple Myeloma in RelapsePoland, Italy, Germany, Denmark, Czechia, Austria
-
AEterna ZentarisCompletedMultiple Myeloma | Multiple Myeloma in Relapse
-
University of PittsburghNovartisWithdrawnMultiple Myeloma | Multiple Myeloma in RelapseUnited States
-
BioSight Ltd.Active, not recruitingRefractory Acute Myeloid Leukemia | MDS | AML, Adult | Relapse/RecurrenceUnited States
-
National Cancer Institute (NCI)Active, not recruitingMyeloma-Multiple | Myeloma, Plasma-CellUnited States
-
National Cancer Institute (NCI)CompletedMyeloma-Multiple | Myeloma, Plasma-CellUnited States
-
Washington University School of MedicineWugen, Inc.WithdrawnMyelodysplastic Syndromes | Refractory Acute Myeloid Leukemia | Relapsed Acute Myeloid Leukemia
-
AmgenCompletedRelapsed or Plateau-Phase Multiple Myeloma
-
Azienda Ospedaliera Universitaria Mater Domini,...Associazione Italiana per la Ricerca sul CancroCompletedAdvanced Solid Tumor | Hepatocarcinoma | Multiple Myeloma, RefractoryItaly
-
Jack KhouriNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Cytokine Release Syndrome | Immune Effector Cell Associated Neurotoxicity SyndromeUnited States
-
Guangzhou Bio-gene Technology Co., LtdRecruitingMultiple Myeloma in RelapseChina
-
Universitätsklinikum Hamburg-EppendorfRecruitingMultiple Myeloma | Multiple Myeloma in RelapseGermany
-
Zhejiang UniversityYake Biotechnology Ltd.Not yet recruitingRelapse Multiple MyelomaChina
-
Washington University School of MedicineBristol-Myers Squibb; CelgeneActive, not recruitingMultiple Myeloma in RelapseUnited States, Canada
-
Oncopeptides ABWithdrawnMultiple Myeloma | Relapse Multiple MyelomaCzechia
-
Shenzhen Second People's HospitalUnknownMultiple Myeloma in RelapseChina
-
University Hospital FreiburgMerck Sharp & Dohme LLC; Janssen-Cilag Ltd.Completed